There were no significant differences in the demographics and characteristics of the study population (age, BMI, creatinine, β2m, albumin, calcium, gender, bone lytic lesions, fractures, myeloma type, anemia, the percentage of the plasma cell, stage, and performance status). The gene discussed is ALB; the disease is plasma cell myeloma.